Drug Shortage Report for CONSTELLA
Report ID | 84767 |
Drug Identification Number | 02417162 |
Brand name | CONSTELLA |
Common or Proper name | CONSTELLA 145MCG CAP 30 CA |
Company Name | ABBVIE CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | Linaclotide |
Strength(s) | 145MCG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | CONSTELLA 145MCG CAP 30 CA |
ATC code | A06AX |
ATC description | DRUGS FOR CONSTIPATION |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2019-05-24 |
Actual start date | 2019-05-24 |
Estimated end date | 2019-06-10 |
Actual end date | 2019-06-10 |
Shortage status | Resolved |
Updated date | 2019-06-11 |
Company comments | Potential issue with the label |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 8401 TRANS-CANADA HIGHWAY SAINT-LAURENT, QUEBEC CANADA H4S 1Z1 |
Company contact information | Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2019-06-11 | English | Compare |
v8 | 2019-06-10 | French | Compare |
v7 | 2019-06-10 | English | Compare |
v6 | 2019-06-06 | French | Compare |
v5 | 2019-06-06 | English | Compare |
v4 | 2019-05-27 | French | Compare |
v3 | 2019-05-27 | English | Compare |
v2 | 2019-05-25 | French | Compare |
v1 | 2019-05-25 | English | Compare |
Showing 1 to 9 of 9